Glucose lowering by continuous tube feeding and Vildagliptin in addition to insulin in hyperglycaemic acute stroke patients.

Trial Profile

Glucose lowering by continuous tube feeding and Vildagliptin in addition to insulin in hyperglycaemic acute stroke patients.

Discontinued
Phase of Trial: Phase III

Latest Information Update: 03 Aug 2013

At a glance

  • Drugs Insulin (Primary) ; Vildagliptin (Primary)
  • Indications Hyperglycaemia
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms GLUCOVAS
  • Most Recent Events

    • 03 Aug 2013 Status changed from recruiting to discontinued as reported by European Clinical Trials Database.
    • 01 Aug 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top